Increasing Survivability and Thrivability for Preterm Infants

Our Story

The inspiration behind Amnion Life, a medical device company occurred 4 years ago during a family trip where we visited a cousin in Europe. They had a beautiful little 3 year old girl who we knew was born very preterm and had a long NICU stay.

This led to complications, including ocular and neurodevelopmental injuries.  She needs and will continue to need daily assistance.  The overall emotional and financial stress for her parents is immeasurable.

3 weeks later on the same trip, I had a dream that preterm infants should be placed in synthetic amniotic fluid, a controlled bath.  The idea, to keep preemies warm and hydrated during their stay in NICU thus avoiding the root cause of many devastating complications seen today.

The Problem

Per the March of Dimes

  • Premature Birth is the #1 cause of death for babies in the US.
  • The past 25 years saw premature births increase more than 35%.
  • Today, one preemie is born every minute.
  • Survivers often have long-term health problems.
  • This creates a lifetime of financial and emotional costs.

NICU Level 3 & 4 Preemies are

Subject To:

Leading To:

  • Brain Hemorrage
  • Necrotizing Enterocolitis
  • Respiratory Distress
  • Bronchopulmonary Dysplasia
  • Periventricular Leukomalacia


  • Apnea
  • Sepsis
  • Meningitis
  • Anemia
  • Convulsions
  • Death
  • During pregnancy, babies live in a comfortable 37°C amniotic fluid which provides total temperature regulation and skin protection.
  • When the pregnancy is interrupted, Babies are thrown into a very hostile environment one that is not built for development of sensitive organs.
  • Subject to hypothermia and dehydration, these babies are subject to all kinds of calamity.

Million Dollar Babies

  • Infants, until the 8th month of pregnancy, are designed for a comfortable 37c fluid environment, with no need for temperature regulation.
  • The skin is permeable and actually absorbing water from the amniotic fluid.
  • When nature’s processes are disrupted the extreme or very preterm infant is born into a cold and hostile” environment.
  • They are no longer absorbing fluid from their surroundings, but instead, are losing large amounts.

At these very early stages of development:

  • The infant has very little subcutaneous fat and 3x surface-area to volume when compared to full terms.
  • This lack of insulation combined with their vessels closeness to the skin causes a large amount of heat loss.
  • Their bodies have yet to develop the heating mechanisms that term infants have such as a shivering mechanism, brown fat, or muscular activity that generates heat.

To compensate, they rev up their metabolism and redirect calories needed for growth towards heat generation further delaying the development of their natural heating mechanisms. The combination of Hypothermia and Dehydration is devastating to all preterm infants.  The extreme preterm infants can have lengthy NICUs stays of 110 days average and are often referred to as million dollar babies.

The incidence of hypothermia in low and very low birth weight preemies.

  • A minimum of 25% among infants <2500 g birth weight
  • 56% or greater in infants <750 g within 30 minutes of birth 
  • An average of 31-78%in infants <1500 g before admission to neonatal intensive care unit. (Bhatt et al. 2007)

The Solution

Amniobed is inspired by nature

AmnioBed™, the Revolutionary Proprietary MedTech Device

  • A controlled bath environment
  • The infants head kept safely above the fluid line at all times
  • The synthetic fluid is continuously cleaned, monitored, refreshed, and heated
  • The osmolality adjusted by medical staff

AmnioBed  recreated the in-womb conditions that allow the infant to survive and thrive.

  • AmnioBed™ is fluid filled incubator intended to create a warm and safe environment for growth and development of preterm infants.

  • Five Medical grade water purification filters eliminating heavy metals, contaminants, and microorganisms from the hospital water supply and bringing the water to dialysis grade purification standards.

  • A medical grade heating system to create on-demand warm water at 98.6F.

  • Significant safety mechanisms for fluid temperature regulation.

  • Custom made disposable cartridges filled with concentrated electrolyte and mineral content.

  • Computer operated dosing pump mixing concentrated electrolyte and mineral solution with purified water.

  • Capability to adjust synthetic amniotic fluid osmolality from 280mosm/ml to 240 mosm/ml per medical team requirements and infant needs.

  • Sterile and disposable bath cover and infant harness made of medical grade plastics.

  • Safety chest and pelvic harness to prevent the infant from submerging into the fluid.

  • Ergonomically designed infant bed for comfortable positioning of the infant.

  • Comfortable and natural fluid environment for infant exercising of arms and legs.

  • Continous filtration of bath fluid through medical grade UV filters.

  • Fluid clarity sensor to detect stool and automatically flush bath fluid when infant defecates.

  • Specially designed infant cap with built-in ECG sensors, EEG sensors, Infrared sensor, skin temperature sensor, O2 Saturation sensor and cap opening on the anterior fontanelle for ultrasound probe placement.

  • Bridge and anchor over the fluid to protect the umbilical catheters from getting submerged.

  • Audio and Video feed to a smart app on mother's phone for remote visual observation of infant at all times and for remotely speaking to the infant and exposure of the infant to mother's voice.

Question: What about possible infection when an infant stools or urinates in the water bath?

Amir Fassihi MD Answers: Infant in AmnioBed sits on a donut shaped cushion. The fluid directly below the genitals is constantly monitored for stool content and if stool is detected, the computer system automatically flushes the bath fluid and replaces it with fresh warm synthetic amniotic fluid. The fluid in the bath is also continuously circulated through a UV filter that kills 99% of pathogens on every pass. Infant urine in the bath is not a problem as natural amniotic fluid in mother’s womb is mostly made of fetal urine.

System will be able to flush out the fluid with new fluid via a sensor in the system

Our patented incubator system – AmnioBed

Question: How will you maintain the sterile environment in the AmnioBed™

– when the infant is connected to intravenous lines, an umbilical catheter, an endotracheal tube, has a functioning GI tract and is accessed by medical staff and the family?

Amir Fassihi MD Answers:  Thank you for our very important question. We’ve spent 3 years on R&D on this element and safety mechanisms in our patent application are what makes our IP unique in this field and why we think we will be the leaders in next generation of synthetic amniotic fluid incubators for preterm infants.

In AmnioBed, the infant is safely and securely harnessed in the bath on angled seat with head and neck above fluid line at all times. The infant wears a head cover/device which partly helps to reduce heat and water loss from head and neck area, but also has important sensors such skin temperature monitoring and O2 saturation monitoring. It also has a fluid sensor on the chin area which can detect fluid if levels rise above the chin so that it can automatically lower fluid level and inform nursing.

We are working on either placing the ECG leads partly on the head/scalp monitoring device or possibly on the bath itself and pick on signal in the bath. Our concern at this time is the noise level on the signal and we will have to do some testing to see where is the best place to capture ECG signal for monitoring. On the central lines, we are developing an umbilical catheter anchoring system to help maintain umbilical catheters isolated from bath fluid at all time. How it works is that in current practice the umbilical cord is cut at 5cm from abdominal wall. We are going to ask cord to be cut at 6-10cm from abdominal wall. The distal 1cm tip of the cord will be anchored device above the fluid line.

The catheter is inserted from the distal tip above the fluid line and anchored in place together with the distal tip of the cord. A plastic splash-proof cover is then being developed to cover the catheter from splashes. As far as peripheral lines, that would be in further development down the line and not necessary in the initial clinical trials and initial infant population if infant has umbilical catheter in place.

But if our device proves to be safe for longer than life of umbilical catheters, our current strategy is to float the extremity and cover with splash-proof cover. We are going to add some new 3D rendered images of the infant in the seat with the infant seat, head scalp monitoring and umbilical catheter.

The fluid in the bath is continuously cleaned, monitored, refreshed, filtered, heated and its osmolality adjusted according to medical needs. If stool particles are detected by our sensors, there is automatic flushing of fluid and replacement with clean warm simulated amniotic fluid. We are going to add some new 3D rendered images of our seat, scalp monitoring device and umbilical catheter anchoring system on our updates on our website this week. Thank you for your very important question and interest.

Question: What are the implications with possible drowning of an infant?

Amir Fassihi MD Answers: We’ve designed a special seat with cover/harness which the infant sits in and contains the fluid. The infant is seated similar to an infant on a car seat with harness over the pelvis and chest. The harness prevents infant from slipping down into the fluid. We’ve also designed special head gear for infant monitoring devices as O2 and skin tempreture which includes a fluid sensor place on the chin area. The sensor is linked to device computer system and device will automatically lower fluid level if it senses chin being submerged.

Question: NICU Nurse Asks About Positioning, Kangaroo Care & I.V. Lines

The neonate’s in your incubator don’t appear to have any boundaries. As a NICU nurse, this concerns me. Being at the bedside, we see a direct correlation in stable vital signs and lower oxygen needs when our infants are positioned correctly. They are more comfortable, they sleep better, and their weight gain is improved. I even personally feel like it aids in digestion, as I see less reflux and residuals when my infant is calm and contained. We use a z-flow pad and tube to position all our micropreemies; this keeps their position as close to the womb as possible while also providing them a boundary to push and kick against. How will we provide boundaries for an infant surrounded by fluid?

Of course I am also wondering how we will safely secure umbilical lines, PICC lines, peripheral IVs, and PALs, and then also be able to position that limb correctly to provide comfort and security to the baby.

What about kangaroo care? We start kangaroo care on day five of life, even in a 23 weeker who is intubated, if they are stable enough. What will be the ramifications of an infant having to be removed from that environment possibly one or more times daily? Will there be a way to weigh the infant each day without draining the fluid? How will we maintain temperature stability if we are constantly draining and re-filling the fluid?

Amir Fassihi MD Answers: Thank you for your thoughtful and expert questions. These are matters which have preoccupied our research and thought for three years and I am glad you are addressing it as well.

As far as positioning of the infant, we are currently working on an ergonomic comfortable seat with special head rests made for the infants. We are currently trying to do some R&D on adjustable head and neck rest so that a nurse can adjust the head and neck rest similar to a car seat. However, please note that the current design will likely be significantly changed and redone as we progress through usability studies and clinical trials. We are currently projecting a pilot study of 5-10 infants for a maximum of 60 minute bath. We will learn many things from such a trial. However, we have a long way to go with usability testing of the device by nurses (without an infant) followed by potential animal studies before we can do the final design of the seat and neck/headrest.  (see photos below on head positioning)

Regarding your question about fetal in-womb push against amniotic sac which aids in bone development, this is also something we’ve taken into consideration. Our challenge in this regard is similar to the current incubator technology. In the current incubators, the infants also don’t have the natural amniotic sac to push against which aids in musculoskeletal development. What we’ve considered is a slightly heavy see-through plastic cover on the infant which can simulate the pressure and comfort of the amniotic sac. But since our initial trials will be in 60 minute or later on on less than 24 hour stays, we are going to tackle that issue when we further design the device for longer AmnioBed stays of >24 hours.

Regarding your concerns about central lines and PICC lines, this is perhaps our most important challenge and something we’ve done significant work on. This is a very important point you have raised. Please refer to Dr Hardy’s questions on our website under FAQ.  In addition, photos of how we will attach IV lines via the umbilical cord can be found under the section:  Updates From Our Research Facility.

Regarding Kangaroo care, our device will have the same restrictions for removal from the incubator as the current convection incubators. Infants can be removed for kangaroo care and placed back into the incubator at any time if kangaroo care is deemed safe by the nurse and medical staff.

Regarding nursing consultants, that is on our wish list at the moment for the company, but we are limited on funds and still early in the product development. I’ve had the opportunity to discuss our concerns and seek input from NICU nurses unofficially, but with the limited budget we’ve had, we decided that we need expert neonatologists first to make sure all medical needs and concerns are addressed prior to working on the details of the nursing requirements and needs such as positioning and device everyday usability and ease of use. 

We look forward to answering any questions you may have. You can submit your questions on our contact us page.

Who benefits:

  • The caregivers who deal with these life and death situations daily
  • Parents who can only stand by and cheer for their hopes and dreams to be realized while in the back of their mind, worrying about the financial implications.
  • The public and private insurers who fund health for their insured will stand to save billions.
    • For the reduction of time in the NICU that each infant will benefit from
    • For the reduction of a lifetime of expenses covering the infant’s complications into childhood and beyond.
  • And then there is the preemie who stands a better chance of having a normal life.

Amnion Life is dedicated to drastically improve the care of preterm infants.

Our Team

Visionary/Founder/Team Builder/CEO

Amir Fassihi M.D.

Amir Fassihi, M.D., is an accomplished radiologist who practices in Orange County, CA. As the company director, Dr. Fassihi has not drawn a salary from Amnion Life and has personally invested in the business.

Dr. Fassihi performed his undergraduate work in the field of biology and ecology at UCLA. He was ranked 161 amongst a pool of nearly 35,000 applicants to UCSF School of Medicine for the 1995 incoming class. Upon obtaining his medical degree from UCSF, he spent a year as an intern in general medicine department at VA/West LA Medical Center followed by residency in field of radiology at Keck/USC Medical Center followed by a year of fellowship in Neuroradiology during which time he was the Chief Fellow.

He is a full-time radiologist working as a teleradiologist for Virtual Radiologic and he plans to continue his full-time work as a radiologist during the upstart stage of Amnion Life. Dr. Fassihi intends to initiate operations as the CEO to ensure a smooth operations transition and to build a culture for employees to share in the same dedication and work towards the success of Amnion Life.

Executive Team

Molly Ferris

Business & Market Development Consultant

Molly’s senior-level leadership and strategic planning expertise encompass pre-commercial regulatory, reimbursement and market entry alignment, strategic market development, market identification, and overall business infrastructure planning for startup, and high-growth companies across multiple industries and a specialty within the medical device industry. She has a strong understanding of healthcare and medical market environments across consumer, hospital, clinical, government, and military segments, and various vertical markets.

Beyond the dream



US Patent No. 15,342,988 and US Patent No 10,166,161 – Intellectual Property (IP) is represented by Knobbe and Martens law firm who specializes in Intellectual Property strategy, both defensive patent aggregation (DPA) and offensive patent aggregation (OPA). Currently pending in Europe

Amnion Life’s R&D Facility Featuring Our Non-Sterile Clean Room in Serbia

Our Milestones, Progress to Date


Where your Investment will take us

The Market

The Market (US Only)

Over $43 Billion is spent annually in the United States on costs associated with premature births.

This includes hospital costs, physician support, and other expenses.

  • The US ranks 6th in the number of premature births when compared to other countries.
  • The Centers for Disease Control and Prevention (CDC) estimated US premature births in 2016 at 388,130 per year.
  • India ranks first among all counties with more than 3.5 Million premature births per year. Globally there are an estimated 15 Million premature births per year.

1/3 of those born are very or extreme preterm and ideally suited for AmnioBed.

The U.S. Market

648 NICU Facilities

19,600 Total Beds

Level iii and Level iV NiCUs

AmnioBed Market Segment (U.S. Only)



For investment information, please contact:

Amir Fassihi

Subscribe for Updates